Faruk COŞKUN, Nurettin KAHRAMANSOY, Polat Arife DÜZGÜN, M. Mahir ÖZMEN, Selda SEÇKİN, Balcı Mahi ÖZGEDİK

The Effect of Erythropoietin in Acute Pancreatitis: An Experimental Study

Background: Although the pathogenesis of acute pancreatitis is not clearly known, the most frequently mentioned factors are proinflammatory cytokines and nitric oxide (NO), which is stimulated by bacterial endotoxins. The relationship of erythropoietin (EPO), which is an erythroid line growth hormone, with proinflammatory cytokines and NO is also not clear. EPO has a well-known general tissue protective effect, yet its role in an inflammatory presentation like that of acute pancreatitis has not been investigated and documented. Therefore, the aim of this study was to investigate the role of EPO in acute pancreatitis. Materials and Methods: 60 Wistar Albino rats were divided into 4 groups as follows: laparotomy (I), pancreatitis (II), pancreatitis + simultaneous application of EPO (III) and finally pancreatitis + administration of EPO after 3 hours (IV). The groups were further separated to subgroups by sacrificing the animals at 3, 6 and 24 hours. Pancreatitis was induced by injecting 4.5% sodium (Na)-taurocholate (0.1 ml / 100 g) into the pancreatic canal. Leukocyte counts and serum amylase and C-reactive protein (CRP) levels were measured. Histopathological changes of the pancreas were evaluated according to Spormann scores. Results: EPO was shown to increase leukocyte counts in the early phase (P < 0.05) though the effect diminished in time. It also had an increasing effect on amylase in the early hours (P < 0.005), but the difference between the groups disappeared in the following hours. No effect was demonstrated on serum CRP. Pancreatic tissue revealed moderate degree of pancreatitis in group III sacrificed at 6 hours and in group IV evaluated at 6 and 24 hours. Despite the absence of a difference in the numerical analysis of Spormann scoring (P > 0.05), moderate pancreatitis developed in the group receiving EPO. Conclusions: The results we have obtained demonstrate that more controlled models (employing low rates of sodium taurocholate or edematous pancreatitis) are necessary to better investigate the efficacy of EPO.

Anahtar Kelimeler:

Acute pancreatitis, experimental model, histopathology, erythropoietin

The Effect of Erythropoietin in Acute Pancreatitis: An Experimental Study

Keywords:

Acute pancreatitis, experimental model, histopathology, erythropoietin,

PDF

___

Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene
expression in rat pancreatic acinar cells is an early event associated
with acute pancreatitis. Gastroenterology. 1997; 113(6): 1966- 1975.
Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS,
Gower WR Jr. Interleukin-1 receptor antagonist decreases
severity of experimental acute pancreatitis. Surgery. 1995; 117(6): 648-655. 9.
Scholmerich J. Interleukins in acute pancreatitis. Scand J
Gastroenterol Suppl. 1996; 219: 37-42.
Rau B, Poch B, Gansauge F, Bauer A, Nussler AK, Nevalainen T et al. Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann Surg. 2000; 231(3): 352-360.
Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG. Differential effects of caspase-1/interleukin-1 beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest. 2001 Jul; 81(7): 1001- 1013.
Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 1997; 1; 100(7): 1853- 1862.
Akimoto T, Kusano E, Fujita N, Okada K, Saito O, Ono S et al. Erythropoietin modulates angiotensin II- or noradrenaline- induced Ca (2+) mobilization in cultured rat vascular smooth- muscle cells. Nephrol Dial Transplant. 2001; 16(3): 491-499.
Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A. 2001; 27; 98(7): 4044-4049. Epub 2001 Mar 20.
Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998; 14; 95(8): 4635-4640.
Rau B, Bauer A, Wang A, Gansauge F, Wiedenbach H. Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers. Ann Surg. 2001; 233(2): 195-203.
al-Mufti RA, Williamson RC. Experimental models of pancreatitis. Ann Acad Med Singapore. 1999; 28(1): 133-140.
Weber A, Friess H, Sill U, Buchler M. The closed duodenal loop technique. Eur Surg Res. 1992; 24 Suppl 1: 24-28.
Nevalainen TJ, Aho HJ. Standards of morphological evaluation and histological grading in experimental acute pancreatitis. Eur Surg Res. 1992; 24 Suppl 1: 14-23.
Spormann H, Sokolowski A, Letko G. Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Pathol Res Pract. 1989; 184(5): 507-513.
Ranson JHC. Acute pancreatitis. In: Schwartz SI, Ellis H, Cowles W, editors. Maingot’s Abdominal Operations. 1997; pp 1899- 1916. Pezzilli R, Melzi d'Eril GV, Morselli-Labate AM, Merlini G, Barakat B, Bosoni T. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci. 2000; 45(6): 1072-1078.
Paajanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I. Serum tumour necrosis factor compared with C- reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg. 1995; 82(2): 271-273.
Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin- 6 levels in ERCP-induced pancreatitis. Gastrointest Endosc. 2001; 54(4): 435-440.
Kazmierczak SC. Biochemical indicators of acute pancreatitis. In: Lott JA, editor. Clinical Pathology of Pancreatic Disorders. Totowa, New Jersey: Humana Press; 1997. pp. 75-124.
Raraty M, Ward J, Erdemli G, Vaillant C, Neoptolemos JP, Sutton R, Petersen OH. Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A. 2000; 21: 97(24): 13126- 13131.
Cheung JY, Zhang XQ, Bokvist K, Tillotson DL, Miller BA. Modulation of calcium channels in human erythroblasts by erythropoietin. Blood. 1997; 89(1): 92-100.
Chu X, Cheung JY, Barber DL, Birnbaumer L, Rothblum LI, Conrad K, Abrasonis V, Chan YM, Stahl R, Carey DJ, Miller BA. Erythropoietin modulates calcium influx through TRPC2. J Biol Chem. 2002; 277(37): 34375-34382. Epub 2002 Jul 11.
Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997; 76(1): 105-116.
Juul SE, Joyce AE, Zhao Y, Ledbetter DJ. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res. 1999; 46(3): 263-268.
Juul SE, Ledbetter DJ, Joyce AE, Dame C, Christensen RD, Zhao Y et al. Erythropoietin acts as a trophic factor in neonatal rat intestine. Gut. 2001; 49(2): 182-189.
Kusano E, Akimoto T, Inoue M, Masunaga Y, Umino T, Ono S et al. Human recombinant erythropoietin inhibits interleukin-1 beta- stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells. Nephrol Dial Transplant. 1999; 14(3): 597-603.
Schobersberger W, Hoffmann G, Fandrey J. Nitric oxide donors suppress erythropoietin production in vitro. Pflugers Arch. 1996; 432(6): 980-985.
Jelkmann W, Hellwig-Buergel T. Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production. Exp Hematol. 1999; 27(2): 224-228. Krafte-Jacobs B, Bock GH. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock. Crit Care Med. 1996; 24(9): 1455-1459.
Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol. 2000; 401(3): 349-356.